XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe Patient Counseling Information

(antihemophilic factor [Recombinant])

17 PATIENT COUNSELING INFORMATION

Advise patients to:

  • read the FDA-approved patient labeling (Patient Information and Instructions for Use).
  • report any adverse reactions or problems that concern them when taking XYNTHA to their healthcare provider.
  • discontinue use of the product, call their healthcare provider, and go to the emergency department if any allergic-type hypersensitivity reactions occur. Inform patients of the early signs of hypersensitivity reactions (including hives [rash with itching]), generalized urticaria, tightness of the chest, wheezing, hypotension) and anaphylaxis.
  • contact their healthcare provider if they experience a lack of a clinical response to factor VIII replacement therapy, as this may be a manifestation of an inhibitor.
  • notify their healthcare provider if they become pregnant or intend to become pregnant during therapy, or if they are breastfeeding.
  • Local irritation may occur when infusing XYNTHA SOLOFUSE.

For Medical Information about XYNTHA, please visit www.pfizermedinfo.com or call 1-800-438-1985.

Find XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe medical information:

Find XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

XYNTHA® Solofuse Lyophilized Powder for Solution in Prefilled Dual-chamber Syringe Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise patients to:

  • read the FDA-approved patient labeling (Patient Information and Instructions for Use).
  • report any adverse reactions or problems that concern them when taking XYNTHA to their healthcare provider.
  • discontinue use of the product, call their healthcare provider, and go to the emergency department if any allergic-type hypersensitivity reactions occur. Inform patients of the early signs of hypersensitivity reactions (including hives [rash with itching]), generalized urticaria, tightness of the chest, wheezing, hypotension) and anaphylaxis.
  • contact their healthcare provider if they experience a lack of a clinical response to factor VIII replacement therapy, as this may be a manifestation of an inhibitor.
  • notify their healthcare provider if they become pregnant or intend to become pregnant during therapy, or if they are breastfeeding.
  • Local irritation may occur when infusing XYNTHA SOLOFUSE.

For Medical Information about XYNTHA, please visit www.pfizermedinfo.com or call 1-800-438-1985.
Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.